作者: Henrik C. Hansen , George P. Yiannikouros , Janakiram R. Citineni , Robert P. Short , Shubham P. Chopade
DOI:
关键词:
摘要: The present disclosure relates to methods for preparing compounds, which are useful regulating the expression of apolipoprotein A-I (ApoA-1), and in treatment prevention cardiovascular disease related states, including cholesterol- or lipid-related disorders, such as, example, atherosclerosis.